Building on the success of the first edition, this completely revised work surveys the vast amount of research generated in the past five years, resulting in a substantial revision with over 30% new material and over 100 new entries. Expanded sections include Animal Studies, Anxiety and Depression, Drugs, Depression, Disasters, and Psychological and Other Therapies.
Also available online via ScienceDirect (2007) - featuring extensive browsing, searching, and internal cross-referencing between articles in the work, plus dynamic linking to journal articles and abstract databases, making navigation flexible and easy. For more information, pricing options and availability visit [external URL]
* Timely update on the topic of Post-Traumatic Stress Disorder taking into account events such as terrorism and middle east wars
* Includes expanded coverage on anxiety and depression
* Incorporates entries on the advances in our knowledge of immunology, cytokines and cell mediated immunity involved in stress responses and autoimmune diseases such as multiple sclerosis and Type I diabetes
George Fink is a Neuroendocrinologist and Neuropharmacologist who has had a major interest in stress since the start of his career. He was recently appointed Vice President and Director of Research of the Pharmos Corporation in Israel and the United States, and is the former Director of the Medical Research Council's Brain Metabolism Unit and honorary professor in the University of Edinburgh in Scotland. Dr. Fink has published over 340 neuroendocrine papers and several authoritative books, and is past president of the European Neuroendocrine Association.